Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-09-10
2000-04-18
Jarvis, William R. A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31505
Patent
active
060515783
ABSTRACT:
This invention relates to the use of pyrazolopyrimidines and pyrrolopyrimidine of, respectively, the general formula ##STR1## wherein A, X, R.sup.3, R.sup.4 and R.sup.5 are as defined below, and the pharmaceutically acceptable salts of such compounds, to treat, prevent or inhibit certain neuronal and other disorders.
REFERENCES:
patent: 2965643 (1960-12-01), Druey et al.
patent: 3600389 (1971-08-01), Druey et al.
patent: 4213977 (1980-07-01), Schane et al.
patent: 4229453 (1980-10-01), Roth et al.
patent: 4904666 (1990-02-01), Friebe et al.
patent: 5063245 (1991-11-01), Abreu et al.
patent: 5646152 (1997-07-01), Bright et al.
patent: 5674998 (1997-10-01), Boyer et al.
Lyons M.K. et al, Brain Res. (Netherlands) vol, 545, No. 1-2 1991, pp. 339-342.
Widmaier E.P. et al. Am. J. Physiol. vol. 255 No. 3--pp. 287-292, 1988.
Haines S. T. et al. Ann. Pharmacoter. vol. 28, No. 6, 1994, p. 781.
Klawans H. L. et al., Clinical Neuropharmacology, vol. 9, No. 2, 1986, pp. 202-205.
Owens, M.J. et al. "Physiology and Pharmacology of Corticotropin-releasing factor" Pharm. Rev., vol. 43, 1991, pp. 425-473.
Robins, Can. J. Chem., 55, 1251 (1977).
Senga et al. J. Heterocyclic Chem., 19, 1565 (1982).
DeRoth, L., Annals New York Acc. Sci., 1993, p. 285.
Strijbos P.J.L..M. et al Brain Res. (Netherlands) vol. 656, No. 2, 1994, pp. 405-408.
Search Report for EP 9630093, 1997.
Ginsburg Paul H.
Jacobs Seth
Jarvis William R. A.
Pfizer Inc.
Richardson Peter C.
LandOfFree
Pyrazolopyrimidines for treatment of CNS disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazolopyrimidines for treatment of CNS disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolopyrimidines for treatment of CNS disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2336615